Works matching IS 17407745 AND DT 2024 AND VI 21 AND IP 1

Results: 14

2023 Peer Reviewers.

Published in:: Clinical Trials, 2024, v. 21, n. 1, p. 138, doi. 10.1177/17407745241226747
Publication type:: Article

Patient-reported measures of tinnitus for individuals with neurofibromatosis type 2–related schwannomatosis: Recommendations for clinical trials.

Published in:

Clinical Trials, 2024, v. 21, n. 1, p. 18, doi. 10.1177/17407745231217279

By:

Thompson, Heather L;
Grabowski, Jane;
Franklin, Barbara;
Koetsier, Kimberley S;
Welling, D Bradley

Publication type:

Article

Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey.

Published in:

Clinical Trials, 2024, v. 21, n. 1, p. 73, doi. 10.1177/17407745231209224

By:

Wolters, Pamela L;
Ghriwati, Nour Al;
Baker, Melissa;
Martin, Staci;
Berg, Dale;
Erickson, Gregg;
Franklin, Barbara;
Merker, Vanessa L;
Oberlander, Beverly;
Reeve, Stephanie;
Rohl, Claas;
Rosser, Tena;
Vranceanu, Ana-Maria

Publication type:

Article

Gene-targeted therapy for neurofibromatosis and schwannomatosis: The path to clinical trials.

Published in:

Clinical Trials, 2024, v. 21, n. 1, p. 51, doi. 10.1177/17407745231207970

By:

Staedtke, Verena;
Anstett, Kara;
Bedwell, David;
Giovannini, Marco;
Keeling, Kim;
Kesterson, Robert;
Kim, YooRi;
Korf, Bruce;
Leier, André;
McManus, Miranda L;
Sarnoff, Herb;
Vitte, Jeremie;
Walker, James A;
Plotkin, Scott R;
Wallis, Deeann

Publication type:

Article

Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials.

Published in:

Clinical Trials, 2024, v. 21, n. 1, p. 6, doi. 10.1177/17407745231205577

By:

Merker, Vanessa L;
Thompson, Heather L;
Wolters, Pamela L;
Buono, Frank D;
Hingtgen, Cynthia M;
Rosser, Tena;
Barton, Belinda;
Barnett, Carolina;
Smith, Taylor;
Haberkamp, Diana;
McManus, Miranda L;
Baldwin, Andrea;
Moss, Irene P;
Röhl, Claas;
Martin, Staci

Publication type:

Article

What influences trust in and understanding of clinical trials? An analysis of information and communication technology use and online health behavior from the Health Information National Trends Survey.

Published in:

Clinical Trials, 2024, v. 21, n. 1, p. 95, doi. 10.1177/17407745231204813

By:

Occa, Aurora;
Merritt, Allison S;
Leip, Allison;
Stapleton, Jerod L

Publication type:

Article

Determining a risk-proportionate approach to the validation of statistical programming for clinical trials.

Published in:

Clinical Trials, 2024, v. 21, n. 1, p. 85, doi. 10.1177/17407745231204036

By:

Gamble, Carrol;
Lewis, Steff;
Stocken, Deborah;
Juszczak, Edmund;
Bradburn, Mike;
Doré, Caroline;
Kean, Sharon

Publication type:

Article

Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials.

Published in:

Clinical Trials, 2024, v. 21, n. 1, p. 40, doi. 10.1177/17407745231203330

By:

Sundby, R Taylor;
Rhodes, Steven D;
Komlodi-Pasztor, Edina;
Sarnoff, Herb;
Grasso, Vito;
Upadhyaya, Meena;
Kim, AeRang;
Evans, D Gareth;
Blakeley, Jaishri O;
Hanemann, C Oliver;
Bettegowda, Chetan

Publication type:

Article

Estimating counterfactual placebo HIV incidence in HIV prevention trials without placebo arms based on markers of HIV exposure.

Published in:

Clinical Trials, 2024, v. 21, n. 1, p. 114, doi. 10.1177/17407745231203327

By:

Zhu, Yifan;
Gao, Fei;
Glidden, David V;
Donnell, Deborah;
Janes, Holly

Publication type:

Article

Advancing neurofibromatosis and schwannomatosis clinical trial design: Consensus recommendations from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration.

Published in:

Clinical Trials, 2024, v. 21, n. 1, p. 3, doi. 10.1177/17407745231201345

By:

Merker, Vanessa L;
Gross, Andrea M;
Widemann, Brigitte C;
Plotkin, Scott R

Publication type:

Article

Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1.

Published in:

Clinical Trials, 2024, v. 21, n. 1, p. 29, doi. 10.1177/17407745231201338

By:

Gross, Andrea M;
Plotkin, Scott R;
Watts, Nelson B;
Fisher, Michael J;
Klesse, Laura J;
Lessing, Andrés J;
McManus, Miranda L;
Larson, A Noelle;
Oberlander, Beverly;
Rios, Jonathan J;
Sarnoff, Herb;
Simpson, Brittany N;
Ullrich, Nicole J;
Stevenson, David A

Publication type:

Article

Controls, comparator arms, and designs for critical care comparative effectiveness research: It's complicated.

Published in:

Clinical Trials, 2024, v. 21, n. 1, p. 124, doi. 10.1177/17407745231195094

By:

Ford, Verity J;
Klein, Harvey G;
Danner, Robert L;
Applefeld, Willard N;
Wang, Jeffrey;
Cortes-Puch, Irene;
Eichacker, Peter Q;
Natanson, Charles

Publication type:

Article

Book Review – For the common good.

Published in:

2024

By:

Holm, Søren

Publication type:

Book Review

Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials.

Published in:

Clinical Trials, 2024, v. 21, n. 1, p. 67, doi. 10.1177/17407745231178839

By:

Cannon, Ashley;
Sarin, Kavita Y;
Petersen, Andrea K;
Pichard, Dominique C;
Wolters, Pamela L;
Erickson, Gregg;
Lessing, Andrés J;
Li, Peng;
Röhl, Claas;
Rosser, Tena;
Widemann, Brigitte C;
Blakeley, Jaishri O;
Plotkin, Scott R

Publication type:

Article